drugset / Trial / NCT00703742

A Neuroimaging and Epigenetic Investigation of Antidepressants in Depression

NCT00703742

NaSingle-groupOpen-labelHealth-services research

Summary

The purpose of this study is: 1. to find out the structural or functional effects of selective serotonin reuptake inhibitors (SSRI) in major depressive disorder (MDD); 2. find special abnormalities in depression secondary to other disease, e.g., autoimmune disease like systemic lupus erythematosus (SLE). 3. find the relationship between the efficacy of antidepressant and the change of neuroimaging in MDD 4. to find possible predispose to MDD 5. to explore the DNA methylation status in depression;

Timeline

Start
2008-06
Primary completion
2011-06
Completion
2011-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Escitalopram Small molecule 20 mg Oral

Indications